Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 12 /hr
Hire Dr. Bharti A.
India
USD 12 /hr
PhD in Cancer Immunology | Scientific Writing with 6+ years of experience, Manuscript Editing, & Literature Review
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
General Proofreading & Editing
Research
Scientific and Technical Research,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Data & AI
Data Processing
Work Experience
Project Scientist
Regional Centre for Biotechnology
February 2024 - Present
Education
PhD
Regional Centre for Biotechnology
June 2020 - September 2025
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Kajal Rana, Ali Khan, Kavthekar Rupesh Namdev, Ruchira Chakraborty, Bharti Aggarwal, Abid Bashir, Neelam Chauhan, Anna Swetha George, Mukesh Singh, Vineet Ahuja, et al. (2026). Oral Delivery of Dendrimer-Derived siRNA-Nanogels Targeting Prostaglandin Metabolism Mitigates Gut Inflammation . Chemistry of Materials.
Shivangi Mishra, Bharti Aggarwal, Prem Singh Anant, Avinash Bajaj, Siddharth Jhunjhunwala (2026). Microparticle uptake reduces efferocytic capacity of macrophages . Biomaterials Science.
Mohammad Nafees Ansari, Jasleen Kaur, Ali Khan, Animesh Kar, Rajeshwari Tripathi, Dolly Jain, Bharti Aggarwal, Avinash Bajaj, Arnab Mukhopadhyay, Ujjaini Dasgupta (2025). Localized Hydrogel-Mediated Docetaxel-Carboplatin Combination Chemotherapy Targets Ganglioside Metabolism to Mitigate Tumor Progression . ACS Pharmacology & Translational Science.
Poonam Yadav, Kajal Rana, Ruchira Chakraborty, Ali Khan, Devashish Mehta, Dolly Jain, Bharti Aggarwal, Somesh K. Jha, Ujjaini Dasgupta, Avinash Bajaj (2024). Engineered nanomicelles targeting proliferation and angiogenesis inhibit tumour progression by impairing the synthesis of ceramide-1-phosphate . Nanoscale.
Bharti Aggarwal, Varsha Saini, Devashish Mehta, Avinash Bajaj (2023). Dimeric Cholic Acid Peptide Conjugates Act as Effective Antibiotic Adjuvants against Multidrug Resistance (MDR) Gram‐Negative Bacterial Infections . Advanced Therapeutics.